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1. Introduction 
The demonstration that la-hydroxyvitamin D3 
(la-OH-Ds) can replace the metabolically active form 
of vitamin Ds, lcy,25dihydroxyvitamin Ds (la,25- 
(OH)z-Ds) in the treatment of various vitamin D 
refractory syndromes [l-3] has prompted investiga- 
tions on the metabolism of this analog. In 1975, we 
synthesized [2-3H]-1~-OH-D3 and demonstrated that 
if was metabolized very rapidly to [3H]-lar,25-(OH)z- 
D3 in perfused rat liver [4]. [3H]-1a,25-(OH)Z-D3 
was found to be the only metabolite of [3H]-lcu-OH- 
D3 produced by the liver [4]. Almost simultaneously, 
Holick et al. synthesized [6-3H]-la-OH-D3 and reached 
the same conclusion from in vivo studies in rats [5] . 
This paper eports in vivo and liver perfusion studies 
showing that 25-hydroxylation of l&OH-D3 by the 
liver is not under metabolic ontrol. 
2. lhaterials and methods 
2.1. Materials 
Crystalline ~cPOH-D3 and lc~,25-(OH)~-D~ were 
kindly donated by Dr I. Matsunaga, Chugai Pharma- 
ceutical Company. [2-3H]-l~-OH-D3 (specific activity, 
4 Ci/mmole) was synthesized in our laboratory 
(Tohira et al., in preparation). 
Weanling pale rats (Sprague-Dawley) were main- 
tained for 6-7 weeks on a vitamin D deficient diet 
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vitamin D,; DHT,, dihydrotachykerol,; 25-OH-DHT,, 
25-hydroxydihydrotachysterol,. 
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[6] before use in in vivo and liver nerfusion studies. 
In some experiments, normal rats fed on a stock diet 
containing vitamin D were used. 
2.2. Liver perfusion studies 
The livers of vitamin D deficient rats were carefully 
removed by the method of Miller et al. [7], and 
perfused with a mixture of heparinized blood (30 ml) 
from vitamin D deficient rats and Krebs-Ringer 
bicarbonate (KRB) buffer, pH 7.4, (45 ml), equili- 
brated with 95% 02, 5% C02. Livers from normal rats 
were perfused with a similar mixture containing blood 
from normal rats. The bile duct was cannulated and 
bile-flow was maintained uring the experiments. When 
the flow of perfusate through the liver (approx. 6 g 
wet weight) attained 30 ml/min, 6.25-62 500 pmol 
of l&OH-D3 containing 0.2 $i of radiochemically 
pure [2-3H]-1~-OH-D3 was added to the perfusate, and 
perfusion was continued for 2 h. In some experiments, 
non-radioactive l&25-(O&-D3 was added to the 
perfusate 30 min before addition of [3H] -la-OH-Ds. 
2.3. In vivo studies 
Vitamin D deficient or normal rats were injected 
intravenously with 6.25 (4 @i/nmole) - 62 500 
(0.04 /Xi/nmole) pmoles of [ 3H] -1 e-OH-D3 and 
killed 2 h later. 
2.4. Measurements of 1q2.5-(OH)2-D3 generated in 
vivo and in perfused rat liver 
The perfusate and liver (perfusion studies), or 
plasma nd liver (in vivo studies) were each extracted 
by the method of Bligh and Dyer [8]. The chloroform 
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layers of the extracts were evaporated to dryness and 
the residues were chromatographed on Sephadex 
LH-20 columns (1.5 X 30 cm) using a solvent of 65% 
chloroform-35% hexane [9]. All radioactive deter- 
minations were carried out with a Packard Tris-Carb. 
Model 3385 liquid scintillation spectrometer. 
[3H]-la,25-(OH)z-Ds was identified by co-chromato- 
graphy with authentic la,25-(OH)2-Ds on Sephadex 
LH-20 column and Celite column, as described previously 
[lo]. The amount of lo,25(OH)*-Ds found in vivo 
or produced in perfused liver was calculated from the 
radioactivity of [3H]-lcr,25-(OH)2-Ds recovered and the 
specific activity of the isotope used. 
3. Results 
At all doses examined, [‘HI -1 o-OH-Da was found 
to be converted to only one radioactive metabolite by 
perfused rat liver. This metabolite was unequivocally 
identified as [‘HI -l~r,25(OH)~ -Ds by co-chromato- 
graphy with authentic lc~,25-(OH)~-Da on Sephadex 
LH-20 and Celite columns. At all doses of above 
250 pmol tested, about 20% of the [ 3H] -1 a-OH-D3 
added was converted to [3H]-la,25-(OH)z-D3 during 
2 h perfusion. The conversion rate was-slightly higher 
at a lower dose. Fig.1 shows the relation between the 
amount of lo-OH-D3 added and that of la,25 
(OH)z-Ds produced by perfused liver. It can be seen 
that the amount of 1(~,25-(0H)~-D~ produced increased 
linearly with increase in the amount of lo-OH-D3 
added. From table 1 it is clear that proir administra- 
tion of large amounts (62.5 nmol) of lo,25-(OH)a-D3 
to the perfusate did not decrease the rate of produc- 
tion of [3H]-1a,25-(OH)2-D3 by the perfused liver. 
Livers from normal rats fed on stock diet also pro- 
duced similar amounts of [3H]-10,25-(OH)2-D3 from 
[3H]-l~-OH-D3 (table 1). 
When vitamin D deficient rats were injected with 
6.25, 62.5, 625, 6250 or 62 500 pmol of [3H]-ls 
OH-D3, the rates of appearance of [3H]-la,25- 
(OH)*-D3 in the plasma and liver increased exactly 
1 O-fold for each 1 O-fold increase in the dose of 
lo-OH-D3 (fig.2). Normal rats fed on stock diet 
metabolized [3H] -lo-OH-D3 to [3H]-10,25-(OH)2-Ds 
at the same rate as vitamin D deficient rats. 
Id-OH-& added ( nmolor ) 
Fig.1. Relation between the amount of la-OH-D, added to the perfusate and that of l&,25-(OH),-D, produced by perfused liver 
from vitamin D deficient rats. ‘Total’ (----•-_) indicates the sum of the amounts of k,25-(OH),-D, recovered in extracts of the 
perfusate (--o-_) and liver (---o-----X 
212 
Volume 65, number 2 FEBS LETTERS June 1976 
Table 1 
Influence of prior administration of vitamin D, or its metabolites in vivo and in vitro 
on the production of l&,25-(OH),-D, from la-OH-D, by perfused rat liver 
Rat Prior additon [3H]-la-OH-D, 
added 
(nmoles) 
lq25-(OH),-D, generated 
Perfusate Liver Total 
(pmoles/h/g of liver) 
D deficient None 2.7 42.2 5.7 47.9 
D deficient b~,25-(0H),-D,~ 2.7 44.7 18.5 63.2 
(62.5 nmol) 
Normal None 2.7 52.2 5.7 57.9 
aThe liver was perfused with 62.5 nmol of non-radioactive lo,25-(OH),-D, for 30 min 
before addition of [‘HI-lo-OH-D,. 
4. Discussion 
Bhattacharyya and DeLuca [ 1 l] compared the 
25-hydroxylations of vitamin Ds and dihydro- 
tachysterola (DHTs), a reduction product of 
tachysterol, and vitamin Da. They demonstrated that 
the rate of appearance of 25-hydroxyvitamin Ds 
(25-OH-Ds) in the blood only increased about 2-fold 
with a loo-fold increase in the dose of vitamin Ds, 
whereas the rate of appearance of 25-hydroxy- 
dihydrotachysterola (25-OH-DHTa) increased 
lOO-fold with a loo-fold increase in the dose of 
DHTa [ll]. 
The present results indicate that the 25-hydroxyla- 
tion of lo-OH-Da by the liver is similar to that of 
DHT3, but not to that of vitamin Ds. Thus, the same 
I& 1 
lif lb’ I IO IO’ 
Iaf-OH-D. aosoa ( nmolor/rot 1 
Fig.2. Relation between the amount of laOH-D, administered and that of la,25(OH),-D, found in the plasma (-o-_) and 
liver (-•----_). 6.25 - 62 500 pmoles of [3H]-lo-OH-D.r were injected into the jugular vein of vitamin D deficient rats, and 
animals were killed 2 h later. 
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liver enzyme may be responsible for the 25hydroxyla- 
tions of lo-OH-Ds and DHTs, but probably not for 
that of vitamin Da. Bhattacharyya and DeLuca con- 
cluded that 25hydroxylation of DHTs, unlike that of 
vitamin Da, is not under metabolic ontrol [ 11,121. 
The same seems true of the 25-hydroxylation of 
lo-OH-D+ 
The present data suggest two important points in 
connection to the treatment of various vitamin D 
refractory syndromes by this analog. First, lo-OH-D3 
administered is metabolized quantitatively to the 
natural hormone of vitamin Da, la,25(OH)2-Ds, and 
this compound is the only metabolite of 1 (w-OH-Da 
generated by the liver. Second, the 25-hydroxylation 
of lo-OH-D3 is not under metabolic ontrol, unlike 
the 25-hydroxylation of vitamin Ds [ 1 l] . Therefore, 
administration of large amounts of lo-OH-Da to 
human patients would certainly induce hypercalcemia. 
Thus, as with lcr,25-(OH)s-Da, care should be taken 
not to administer excess la-OH-Da to human patients. 
Neither lo-OH-Da nor DHTa is a naturally occurring 
form of the D vitamin, but la-OH-Da is metabolized 
very quickly and quantitatively to the natural 
hormone of vitamin Da. In addition, lo-OH-Da is 
much easier and cheaper to prepare than 1 a,25- 
(OH)Z-D3. Therefore, lo-OH-Da seems to be the best 
analog of lc~,25(OH)~-Ds for clinical use. Com- 
parative studies on the 25-hydroxylations of vitamin 
Ds and la-OH-D3 in perfused rat liver are now in 
progress. 
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